Abstract
Urethral bulking agents are a commonly employed modality utilized for treatment of female stress urinary incontinence. These primarily collagen-based agents are placed in the proximal urethra to facilitate mucosal coaptation during increases of intra-abdominal stress. Several known complications of these agents exist, including urethral prolapse, retention, and urinary infection. Herein, we report two cases diagnosed as urethral diverticuli which were ultimately determined anatomic aberration secondary to prior bulking agent therapy. Recognition of this potential sequela of bulking agent placement is important for the female pelvic surgeon to recognize to avoid the morbidity of potential invasive interventions.
This is a preview of subscription content, log in via an institution to check access.
References
Kotb AF, Campeau L, Corcos J (2009) Urethral bulking agents: techniques and outcomes. Curr Urol Rep 10(5):396–400
Handel LN, Leach GE (2008) Current evaluation and management of female urethral diverticula. Curr Urol Rep 9(5):383–388, Review
Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ (2004) Carbon coated zirconium beads in β-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J Urol 171(3):1152–1155
Koski ME, Enemchukwu E, Padmanabhan P, Kaufman MR, Scarpero HM, Dmochowski RR (2011) Safety and efficacy of sling after bulking injection for persistent stress urinary incontinence. Urology 2011 Jan 7. [Epub ahead of print]
Rovner ES (2007) Urethral diverticula: a review and an update. Neurourol Urodyn 26(7):972–977
Rovner ES, Wein AJ (2003) Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol 170:82–86
Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Pons ME, Haab F, Hill S (2005) Stress incontinence injection therapy: what is best for our patients? Eur Urol 48(4):552–565
Clemens JQ, Bushman W (2001) Urethral diverticulum following transurethral collagen injection. J Urol 166(2):626
Corcos J, Fournier C (1999) Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology 54(5):815–818
Shortliffe LMD, Freiha FS, Kessler R et al (1989) Treatment of urinary incontinence by the periurethral implantation of glutaraldehyde cross-linked collagen. J Urol 141:538–541
Herschorn S, Radomski SB, Steele DJ (1992) Early experience with intraurethral collagen injections for urinary incontinence. J Urol 148:1797–1800
O’Connell HE, McGuire EJ, Aboseif S et al (1995) Transurethral collagen therapy in women. J Urol 154:1463–1465
Moore KN, Chetner MP, Metcalfe JB et al (1995) Periurethral implantation of glutaraldehyde cross-linked collagen (Contingen) in women with type I or III stress incontinence: quantitative outcome measures. Br J Urol 75:359–363
Winters JC, Appell RA (1995) Periurethral injection of collagen in the treatment of intrinsic sphincter deficiency in the female patient. Urol Clin North Am 22:673–678
Stothers L, Goldenberg SL, Leone EF (1998) Complications of periurethral collagen injection for stress urinary incontinence. J Urol 159(3):806–807
Sweat SD, Lightner DJ (1999) Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96
Kershen RT, Dmochowski RR, Appell RA (2002) Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium. Urol Clin North Am 29:559–574
McKinney CD, Gaffey MJ, Gillenwater JY (1995) Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J Urol 153:149–151
Lightner DJ, Itano NB, Sweat SD, Chrouser KL, Fick F (2002) Injectable agents: present and future. Curr Urol Rep 3:408–413
Hartanto VH, Lightner DJ, Nitti VW (2003) Endoscopic evacuation of Durasphere. Urology 62:135–137
Chapple C, Sultan AH, Cervigni M (2004) Efficacy and safety of the Zuidex system for the treatment of stress urinary incontinence: 6-month results of an open, multicentre study. Joint Meeting of the International Continence Society and UroGynecological Association, Paris, France, 23–27 August 2004. Abstract 314
van Kerrebroeck P, ter Meulen F, Larsson G, Farrelly E, Edwall L, Fianu-Jonasson A (2004) Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 64:276–281
Stothers L, Goldenberg SL (1998) Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence. J Urol 159:1507–1509
Lightner DJ, Fox J, Klingele C (2010) Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Urology 75(6):1310–1314
McLennan MT, Bent AE (1998) Suburethral abscess: a complication of periurethral collagen injection therapy. Obstet Gynecol 92:650
Coull N, Dover K, Walker RMH (2008) Sterile abscess formation following periurethral injections for stress urinary incontinence—an underestimated complication. Br J Med Surg 1:142–144
Wainstein MA, Klutke CG (1998) Periurethral pseudocyst following cystoscopic collagen injection. Urology 51:835
Harris RL, Cundiff GW, Coates KW, Addison WA, Bump RC (1998) Urethral prolapse after collagen injection. Am J Obstet Gynecol 178(3):614–615
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, D., Kaufman, M.R. & Dmochowski, R.R. Case reports: periurethral bulking agents and presumed urethral diverticula. Int Urogynecol J 22, 1039–1043 (2011). https://doi.org/10.1007/s00192-011-1377-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-011-1377-4